Effect of liver x receptor activation on the very low density lipoprotein secretion and messenger ribonucleic acid level of related genes in goose primary hepatocytes

Poultry Science

Volumn 90, Issue 2, 2011, Pages 402-409

  Han, C C ^a   Wang, J W ^a   Pan, Z X ^a   Tang, H ^a   Xiang, S X ^a   Wang, J ^a   Li, L ^a   Xu, F ^a   Wei, S H ^a  

^a Sichuan Agricultural University   (Taiwan)

Author keywords

Assembly and secretion; Goose; Liver x receptor activation; Very low density lipoprotein triglyceride

Indexed keywords

ANSER;

EID: 79251522535     PISSN: 00325791     EISSN: 15253171     Source Type: Journal    
DOI: 10.3382/ps.2010-00995     Document Type: Article

References (36)

1. Abo-Hashema, K. A. H., M. H. Cake, G. W. Power, and D. Clarke. 1999. Evidence for triacylglycerol synthesis in the lumen of microsomes via a lipolysis-esterification pathway involving carnitine acyltransferases. J. Biol. Chem. 274:35577-35582.
2. Bandsma, R. H. J., C. H. Wiegman, A. W. Herling, H. J. Burger, A. ter Harmsel, A. J. Meijer, J. A. Romijn, D. J. Reijngoud, and F. Kuipers. 2001. Acute inhibition of glucose-6-phosphate translocator activity leads to increased de novo lipogenesis and development of hepatic steatosis without affecting VLDL production in rats. Diabetes 50:2591-2597.
3. Basciano, H., A. Miller, C. Baker, M. Naples, and K. Adeli. 2009. LXRα activation perturbs hepatic insulin signaling and stimulates production of apolipoprotein B-containing lipoproteins. Am. J. Physiol. Gastrointest. Liver Physiol. 297:G323-G332.
4. Chen, H. C., S. J. Stone, P. Zhou, K. K. Buhman, and R. V. Farese Jr. 2002. Dissociation of obesity and impaired glucose disposal in mice overexpressing acyl coenzyme A:diacylglycerol acyltransferase 1 in white adipose tissue. Diabetes 51:3189-3195.
5. Chen, N., L. Liu, Y. Zhang, H. N. Ginsberg, and Y. H. Yu. 2005. Whole-body insulin resistance in the absence of obesity in FVB mice with overexpression of Dgat1 in adipose tissue. Diabetes 54:3379-3386.
6. Cuchel, M., L. T. Bloedon, P. O. Szapary, D. M. Kolansky, M. L. Wolfe, A. Sarkis, J. S. Millar, K. Ikewaki, E. S. Siegelman, R. E. Gregg, and D. J. Rader. 2007. Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia. N. Engl. J. Med. 356:148-156.
7. Day, C. P. 2006. Genes or environment to determine alcoholic liver disease and non-alcoholic fatty liver disease. Liver Int. 26:1021-1028.
8. Fisher, E. A., and H. N. Ginsberg. 2002. Complexity in the secretory pathway: The assembly and secretion of apolipoprotein Bcontaining lipoproteins. J. Biol. Chem. 277:17377-17380.
9. Fossati, P., and L. Prencipe. 1982. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin. Chem. 28:2077-2080.
10. Gibbons, G. F., K. Islam, and R. J. Pease. 2000. Mobilisation of triacylglycerol stores. Biochim. Biophys. Acta 1483:37-57.
11. Grefhorst, A., B. M. Elzinga, P. J. Voshol, T. Plösch, T. Kok, V. W. Bloks, F. H. van der Sluijs, L. M. Havekes, J. A. Romijn, H. J. Verkade, and F. Kuipers. 2002. Stimulation of lipogenesis by pharmacological activation of the liver X receptor leads to production of large, triglyceride-rich very low density lipoprotein particles. J. Biol. Chem. 277:34182-34190.
12. Grefhorst, A., and E. J. Parks. 2009. Reduced insulin-mediated inhibition of VLDL secretion upon pharmacological activation on the liver X receptor in mice. J. Lipid Res. 50:1374-1383.
13. Han, C. C., J. W. Wang, H. Y. Xu, L. Li, J. Q. Ye, L. Jiang, and W. H. Zhuo. 2008. Effect of overfeeding on plasma parameters and mRNA expression of genes associated with hepatic lipogenesis in goose. Asian-australas. J. Anim. Sci. 21:590-595.
14. Jamil, H., C. H. Chu, J. K. Dickson Jr., Y. Chen, M. Yan, S. A. Biller, R. E. Gregg, J. R. Wetterau, and D. A. Gordon. 1998. Evidence that microsomal triglyceride transfer protein is limiting in the production of apolipoprotein B-containing lipoproteins in hepatic cells. J. Lipid Res. 39:1448-1454.
15. Lettéron, P., A. Sutton, A. Mansouri, B. Fromenty, and D. Pessayre. 2003. Inhibition of microsomal triglyceride transfer protein: Another mechanism for drug-induced steatosis in mice. Hepatology 38:133-140.
16. Levin, M. C., M. Monetti, M. J. Watt, M. P. Sajan, R. D. Stevens, J. R. Bain, C. B. Newgard, R. V. Farese Sr., and R. V. Farese Jr. 2007. Increased lipid accumulation and insulin resistance in transgenic mice expressing DGAT2 in glycolytic (type II) muscle. Am. J. Physiol. Endocrinol. Metab. 293:E1772-E1781.
17. Li, X., S. M. Grundy, and S. B. Patel. 1997. Obesity in db and ob animals leads to impaired hepatic very low density lipoprotein secretion and differential secretion of apolipoprotein B-48 and B-100. J. Lipid Res. 38:1277-1288.
18. Liang, J. J., P. Oelkers, C. Guo, P. C. Chu, J. L. Dixon, H. N. Ginsberg, and S. L. Sturley. 2004. Overexpression of human diacylglycerol acyltransferase 1, acyl-CoA:cholesterol acyltransferase 1, or acyl-CoA:cholesterol acyltransferase 2 stimulates secretion ofapolipoprotein B-containing lipoproteins in McA-RH7777 cells. J. Biol. Chem. 279:44938-44944.
19. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using rea1-time quantitative PCR and the 2-ΔΔCt methed. Methods 25:402-408.
20. Menke, J. G., K. L. Macnaul, N. S. Hayes, J. Baffic, Y. S. Chao, A. Elbrecht, L. J. Kelly, M. H. Lam, A. Schmidt, S. Sahoo, J. Wang, S. D. Wright, P. Xin, G. Zhou, D. E. Moller, and C. P. Sparrow. 2002. A novel liver X receptor agonist establishes species differences in the regulation of cholesterol 7alphahydroxylase (CYP7a). Endocrinology 143:2548-2558.
21. Millar, J. S., S. J. Stone, U. J. F. Tietge, B. Tow, J. T. Billheimer, J. S. Wong, R. L. Hamilton, R. V. Farese Jr., and D. J. Rader. 2006. Short-term overexpression of DGAT1 or DGAT2 increases hepatic triglyceride but not VLDL triglyceride or apoB production. J. Lipid Res. 47:2297-2305.
22. Monetti, M., M. C. Levin, M. J. Watt, M. P. Sajan, S. Marmor, B. K. Hubbard, R. D. Stevens, J. R. Bain, C. B. Newgard, R. V. Farese Sr., A. L. Hevener, and R. V. Farese Jr. 2007. Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver. Cell Metab. 6:69-78.
23. Natali, F., L. Siculella, S. Salvati, and G. V. Gnoni. 2007. Oleic acid is a potent inhibitor of fatty acid and cholesterol synthesis in C6 glioma cells. J. Lipid Res. 48:1966-1975.
24. Owen, M. R., C. C. Corstorphine, and V. A. Zammit. 1997. Overt and latent activities of diacylglycerol acyltransferase in rat liver microsomes: Possible roles in very-low-density lipoprotein triacylglycerol secretion. Biochem. J. 323:17-21.
25. Roorda, B. D., M. K. Hesselink, G. Schaart, E. Moonen-Kornips, P. Martínez-Martínez, M. Losen, M. H. De Baets, R. P. Menslink, and P. Schrauwen. 2005. DGAT1 overexpression in muscle by in vivo DNA electroporation increases intramyocellular lipid content. J. Lipid Res. 46:230-236.
26. Seglen, P. O. 1976. Preparation of isolated rat liver cells. Methods Cell Biol. 13:29-83.
27. Shockey, J. M., S. K. Gidda, D. C. Chapital, J.-C. Kuan, P. K. Dhanoa, J. M. Bland, S. J. Rothstein, R. T. Mullen, and J. M. Dyer. 2006. Tung tree DGAT1 and DGAT2 have nonredundant functions in triacylglycerol biosynthesis and are localized to different subdomains of the endoplasmic reticulum. Plant Cell 18:2294-2313.
28. Smith, S. J., S. Cases, D. R. Jensen, H. C. Chen, E. Sande, B. Tow, D. A. Sanan, J. Raber, R. H. Eckel, and R. V. Farese Jr. 2000. Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat. Nat. Genet. 25:87-90.
29. Stone, S. J., M. C. Levin, and R. V. Farese Jr. 2006. Membrane topology and identification of key functional amino acid residues of murine acyl-CoA:diacylglycerol acyltransferase-2. J. Biol. Chem. 281:40273-40282.
30. Stone, S. J., H. Myers, B. E. Brown, S. M. Watkins, K. R. Feingold, P. M. Elias, and R. V. Farese Jr. 2004a. Lipopenia and skin barrier abnormalities in DGAT2-deficient mice. J. Biol. Chem. 279:11767-11776.
31. Stone, S. J., H. M. Myers, S. M. Watkins, B. E. Brown, K. R. Feingold, P. M. Elias, and R. V. Farese Jr. 2004b. Lipopenia and skin barrier abnormalities in DGAT2-deficient mice. J. Biol. Chem. 279:11767-11776.
32. Tietge, U. J., A. Bakillah, C. Maugeais, K. Tsukamoto, M. Hussain, and D. J. Rader. 1999. Hepatic overexpression of microsomal triglyceride transfer protein (MTP) results in increased in vivo secretion of VLDL triglycerides and apolipoprotein B. J. Lipid Res. 40:2134-2139.
33. Waterman, I. J., N. T. Price, and V. A. Zammit. 2002. Distinct ontogenic patterns of overt and latent DGAT activities of rat liver microsomes. J. Lipid Res. 43:1555-1562.
34. Wu, X., M. Zhou, L. S. Huang, J. Wetterau, and H. N. Ginsberg. 1996. Demonstration of a physical interaction between microsomal triglyceride transfer protein and apolipoprotein B during the assembly of ApoB-containing lipoproteins. J. Biol. Chem. 271:10277-10281.
35. Yamazaki, T., E. Sasaki, C. Kakinuma, T. Yano, S. Miura, and O. Ezaki. 2005. Increased very low density lipoprotein secretion and gonadal fat mass in mice overexpressing liver DGAT1. J. Biol. Chem. 280:21506-21514.
36. Yen, C.-L. E., S. J. Stone, S. Koliwad, C. Harris, and R. V. Farese Jr. 2008. DGAT enzymes and triacylglycerol biosynthesis. J. Lipid Res. 49:2283-2301.